Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations-Reference-Cited by-同舟云学术

Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations

Published:2020-09-21 Issue:11 Volume:40 Page:1063-1070
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Narasimhalu Kaavya^ORCID,Ang Yoong Kwei^ORCID,Tan Doreen Su Yin^ORCID,De Silva Deidre Anne^ORCID,Tan Kelvin Bryan^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-020-00970-y.pdf

Reference32 articles.

1. Kernan WN, Ovbiagele B, Black HR, et al (2014) Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association.

2. CAPRIE Steering committee. A randomized blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet. 1996;348:1329–39.

3. Sangkuhl K, Klein TE, Altman RB (2010) Clopidogrel pathway. Pharmacogenet. Genomics.

4. Goh LL, Lim CW, Sim WC, et al. Analysis of genetic variation in CYP450 genes for clinical implementation. PLoS One. 2017. https://doi.org/10.1371/journal.pone.0169233.

5. Aw JWX, Tan DSY, Goh LL (2018) Letter by Aw et al Regarding Article, Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. Circ. Genomic Precis. Med.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review;Pharmacogenomics;2024-09-04

2. CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association;Circulation;2024-08-06

3. Cost-Effectiveness Analysis of Genotype-Guided Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention in Korea;Drug Targets and Therapeutics;2024-03-31

4. Precision medicine in cardiovascular therapeutics: Evaluating the role of pharmacogenetic analysis prior to drug treatment;Journal of Internal Medicine;2024-02-11

5. Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications;Pharmacogenomics;2024-01